Lucica® Glycated Albumin-L liquid marker


Lucica-Glycated-Albumin-L-glycemic-control-marker-2

Key features


  • Specific for glycated albumin (GA)
  • Measures both glycated albumin and total albumin in separate reactions
  • Standarized to an established reference (JCCRM611)
  • Widely published method

Read more 

Glycated Albumin

The Lucica® method for Glycated Albumin (GA), manufactured by Asahi Kasei Pharma Corporation, is a specific test for GA that is now FDA cleared for sale in the U.S. The Lucica® test is distributed exclusively by EKF USA (former Stanbio). The Lucica® test is one of the most widely used and published GA methods worldwide.

What is the Glycated Albumin use?

Lucica® is intended to be used for the quantitative measurement of glycated albumin in human serum on compatible clinical chemistry analyzers. The measurement of GA is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes. For in vitro diagnostic use only.

Lucica® Glycated Albumin-L can fill the gap between long-term and short-term glycemic control marker

What are the advantages of Glycated Albumin testing?

  • Lucica® Glycated Albumin-L is specific for GA. It does not measure other glycated proteins such as glycated immunoglobulins.
  • Measures both glycated albumin and total albumin in separate reactions.
  • Results are expressed as a ratio, thus minimizing differences in protein concentrations between patients.
  • Is standardized to an established reference (JCCRM611) via JSCC (Japan Society of Clinical Chemistry).
  • Over the last decade, numerous studies have been published utilizing the Lucica® methodology.

Exclusively available in the US